Anti-Proliferative Effects of Pistacia atlantica Gum Extract on the Human TC1 Cell line: In Vitro Testing

Cervical cancer is one of the most common cancers in women throughout the globe. According to reports, currently used cervical cancer therapies are harmful to patients. These treatments have also revealed certain adverse effects that may have a severe impact on the lives of women who are afflicted with this kind of cervical cancer. To combat cancer, fewer hazardous anti-tumor therapies are required. Natural products, such as herbal medicine, have been revealed to have a variety of biological impacts. Pistacia atlantica gum extract was tested on the TC1 cell line to see whether it had any anti-proliferative effects.

This study aimed to determine the anti-proliferative effect of Pistacia atlantica gum extract on the TC1 cell line.

Gum extract from dried and milled Pistacia atlantica was analyzed using Gas Chromatography-Mass Spectrometry. The cells were divided into five groups at random, including one for the negative control, one for the positive control, and three for the therapy. Cells from TC1 mice were given the extracts of Pistacia atlantica gum at three different doses (100, 200, and 400 mg/mL). To determine the viability of the cells, reactive oxygen species (ROS) generation, and the concentrations of caspases-3, -8, and -9, researchers used a commercial enzyme-linked immuno-absorbent assay kit.

Results showed that, in comparison to the negative control and most other treatment groups, the Pistacia atlantica gum extract group (400 mg/ml) significantly decreased cell viability (70.138±8.464) and significantly increased apoptosis percentage (71.66±4.041), produced significantly more ROS (15.69±0.799), and significantly increased lactate dehydrogenase release (17.83±0.772) in TC1cells (P<0.05). In addition, the activity of caspase-8 (0.097±0.007) and caspase-9 (0.065±0.004)increased significantly (P<0.05) in this study.

Our findings indicated that Pistacia atlantica gum extract could drastically decrease cell viability and increase apoptosis in the TC1 cell line, similar to the anti-cancer medication doxorubicin.